Literature DB >> 6198681

Pathogenetic aspects of demyelinating lesions in chronic relapsing experimental allergic encephalomyelitis: possible interaction of cellular and humoral immune mechanisms.

H Lassmann, B Schwerer, K Kitz, M Egghart, H Bernheimer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6198681     DOI: 10.1016/S0079-6123(08)63875-3

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


× No keyword cloud information.
  6 in total

1.  Herpes simplex virus-enhanced production of autoantibodies against myelin basic protein in mice.

Authors:  S Gudmundsdottir; B Svennerholm; K Kristensson; E Lycke
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Neuroprotection by ulinastatin in experimental autoimmune encephalomyelitis.

Authors:  Yaqing Shu; Yu Yang; Wei Qiu; Zhengqi Lu; Ying Li; Jian Bao; Ming Feng; Xueqiang Hu
Journal:  Neurochem Res       Date:  2011-06-12       Impact factor: 3.996

Review 3.  Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.

Authors:  Jens Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2010-03       Impact factor: 4.618

4.  Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.

Authors:  Xiaomeng Ma; Ying Jiang; Aimin Wu; Xiaohong Chen; Rongbiao Pi; Mei Liu; Yingying Liu
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

5.  Chronic relapsing experimental allergic encephalomyelitis: its value as an experimental model for multiple sclerosis.

Authors:  H Lassmann
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

6.  Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein.

Authors:  C Linington; M Bradl; H Lassmann; C Brunner; K Vass
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.